Broncus Technologies, Inc.
Provides navigation, diagnostic, and therapeutic technologies to diagnose and treat patients with lung disease.
Launch date
Employees
Market cap
-
Enterprise valuation
€55—82m (Dealroom.co estimates Jun 2018.)
San Jose California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$3.1m | Series B | ||
N/A | Seed | ||
* | $15.0m | Series A | |
N/A | Series C | ||
| N/A | $200m | IPO | |
| Total Funding | €121m | ||
Related Content
Recent News about Broncus Technologies, Inc.
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Broncus Technologies, Inc.
Edit
ACQUISITION by Broncus Technologies, Inc. Aug 2016